How does CRISPR technology target and degrade SARS-CoV-2?

Question

Accepted Answer

CRISPR Technology Targets and Degrades SARS-CoV-2 by Degrading its RNA Genome

Scientists have successfully employed CRISPR gene-editing technology to inhibit the transmission of the SARS-CoV-2 virus within infected human cells. This innovative approach utilizes a specific enzyme, CRISPR-Cas13b, which is engineered to identify and bind to the virus's RNA sequences. Upon binding, the enzyme actively degrades the viral genome, thereby preventing the virus from replicating inside host cells.
Enzyme Binds to Viral RNA Sequences

The core mechanism of this CRISPR application involves the enzyme CRISPR-Cas13b acting as a molecular scalpel. This enzyme is designed to specifically recognize and attach itself to the RNA sequences that constitute the genetic material of the SARS-CoV-2 virus. This precise binding is the crucial first step in neutralizing the virus's ability to proliferate.
Degradation of Viral Genome Prevents Replication

Once CRISPR-Cas13b has successfully bound to the viral RNA, it proceeds to degrade the virus's genome. This process effectively 'chops up' the genetic material necessary for the virus to make copies of itself. By dismantling the viral genome, the technology halts the replication cycle within human cells, thereby blocking further transmission.
Targeting of Both Stable and Changeable Viral Parts

Researchers specifically targeted multiple regions of the SARS-CoV-2 virus, including both highly stable, unchanging sections and more variable parts. This dual targeting strategy proved effective, with all tested components working well in degrading the virus. This approach also demonstrated success in inhibiting viral replication in variants of concern, such as the Alpha variant.

Reading history

Hide →

This history is cleared when the page is closed.

How does CRISPR technology target and degrade SARS-CoV-2?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends